CML patient Rob Shick - OHSU Knight Cancer Institute
Автор: OHSU
Загружено: 2013-09-25
Просмотров: 1032
Описание: When Rob Shick learned he had chronic myelogenous leukemia (CML), he thought it was a death sentence. Now he lives a healthy, productive life thanks to the targeted therapy Gleevec, developed at OHSU by Brian Druker, M.D., in collaboration with Novartis. Shick tells why he is so inspired by the work being done at the OHSU Knight Cancer Institute.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: